"I think it's fascinating that an aspect of how p14 ARF acts as a tumor suppressor is through immobilization of the liquid-like nucleolus and apparent inhibition of critical steps in ribosome ...
These mechanisms, including those involving the tumor suppressor protein p53, are widely studied due to their critical role in disease. Through studies of proteins that regulate p53, scientists at St.
A key SRF partner, Tevard Biosciences, will use the SYNGAP1-Q503X model to test their innovative tRNA suppressor therapy, as illustrated by Tevard's CEO at the 2023 SYNGAP1 Conference. While many RNA ...